SEGLUROMET

Merck Sharp & Dohme LLC🇺🇸 United States

FDA Page

Effective Date: Aug 11, 2026
Approval ID: a6aeb99a-ce49-4125-90ce-642df3f1ebad
Products: 4 registered
Version: 20

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SEGLUROMET safely and effectively. See full prescribing information for SEGLUROMET. SEGLUROMET (ertugliflozin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 2017

Quick Stats

Total Products4

Labelers2

Label Sections23

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.